Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s... Copyright ©2026. All Rights Reserved.

Roche Holding AG has rapidly developed a research use only molecular PCR test to detect the rare Ebola Bundibugyo virus, to support response efforts amid the ongoing outbreak in the Democratic ...

Avelos Therapeutics Inc. has identified new poly(ADP-ribose) glycohydrolase (PARG) inhibitors that are potentially useful for the treatment of cancer.

If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s biotechnology sector, it was that the ...

The microbiome and a frontline innate antimicrobial sensor, Toll-like receptor 5 (TLR5), play an essential role in the ...

TRIM21, an enzyme involved in intracellular substrate degradation, can recognize viruses and bacteria that enter the cytosol when they are coated with antibodies. Just as it tags complex molecules for ...

Genome-wide association studies (GWAS) have identified multiple loci associated with complex diseases, but these are mostly ...

Oppenheimer analyst Jay Olson trumpeted “a new era” in pancreatic ductal adenocarcinoma (PDAC) after Revolution Medicines Inc ...

Eli Lilly and Co. has signed another billion-dollar deal, this time with Boston-based Ascidian Therapeutics Inc., a company that is barely four years old and one that is focused on treating human ...

Shares of Fulcrum Therapeutics Inc. (NASDAQ:FULC) fell 54% after the company said it is discontinuing work on sickle cell ...

New hires and promotions in the biopharma and med-tech industries, including: Celularity, Cocrystal, Corrixr, Cue Biopharma, Defence, Jenavalve, Natera, Neuronetics ...

IMU Biosciences Ltd. has closed its series A at £40 million (US$53.9 million), adding £28.5 million to the initial close in ...